Health Technology Assessment evaluation of the 13-valent pneumococcal conjugate vaccine in the adult and elderly population

Maria Lucia Specchia, Maria Luisa Di Pietro, Chiara Cadeddu, Gualtiero Ricciardi, Chiara De Waure, Francesco Di Nardo, Anna Maria Ferriero, Silvio Capizzi, Maria Assunta Veneziano, Maria Daniela Gliubizzi, F Kheiraoui, L Mantovani, Mr Gualano, N Nicolotti, A Sferrazza, R Saulle, G La Torre

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Nessuno
Original languageEnglish
Title of host publicationProceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
Pages110-111
Number of pages2
Publication statusPublished - 2013
Event10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” - Seoul
Duration: 15 Jun 201319 Jun 2013

Conference

Conference10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
CitySeoul
Period15/6/1319/6/13

Keywords

  • 13-valent Pneumococcal Conjugate Vaccine
  • Adult and Elderly Population
  • Health Technology Assessment

Fingerprint

Dive into the research topics of 'Health Technology Assessment evaluation of the 13-valent pneumococcal conjugate vaccine in the adult and elderly population'. Together they form a unique fingerprint.

Cite this